Correlation Between Freeline Therapeutics and Reneo Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Freeline Therapeutics and Reneo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freeline Therapeutics and Reneo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Freeline Therapeutics Holdings and Reneo Pharmaceuticals, you can compare the effects of market volatilities on Freeline Therapeutics and Reneo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freeline Therapeutics with a short position of Reneo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freeline Therapeutics and Reneo Pharmaceuticals.

Diversification Opportunities for Freeline Therapeutics and Reneo Pharmaceuticals

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Freeline and Reneo is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Freeline Therapeutics Holdings and Reneo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reneo Pharmaceuticals and Freeline Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freeline Therapeutics Holdings are associated (or correlated) with Reneo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reneo Pharmaceuticals has no effect on the direction of Freeline Therapeutics i.e., Freeline Therapeutics and Reneo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Freeline Therapeutics and Reneo Pharmaceuticals

Given the investment horizon of 90 days Freeline Therapeutics Holdings is expected to generate 2.23 times more return on investment than Reneo Pharmaceuticals. However, Freeline Therapeutics is 2.23 times more volatile than Reneo Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Reneo Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  224.00  in Freeline Therapeutics Holdings on August 31, 2024 and sell it today you would earn a total of  207.00  from holding Freeline Therapeutics Holdings or generate 92.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy9.55%
ValuesDaily Returns

Freeline Therapeutics Holdings  vs.  Reneo Pharmaceuticals

 Performance 
       Timeline  
Freeline Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Freeline Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Freeline Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Reneo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Solid
Over the last 90 days Reneo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very unsteady technical indicators, Reneo Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Freeline Therapeutics and Reneo Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Freeline Therapeutics and Reneo Pharmaceuticals

The main advantage of trading using opposite Freeline Therapeutics and Reneo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freeline Therapeutics position performs unexpectedly, Reneo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reneo Pharmaceuticals will offset losses from the drop in Reneo Pharmaceuticals' long position.
The idea behind Freeline Therapeutics Holdings and Reneo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Transaction History
View history of all your transactions and understand their impact on performance